piperidine-1-propanesulphonic acid
- $106 - $936
- Product name: piperidine-1-propanesulphonic acid
- CAS: 1132-60-1
- MF: C8H17NO3S
- MW: 207.29
- EINECS:214-476-4
- MDL Number:MFCD00023783
- Synonyms:piperidine-1-propanesulphonic acid ;1-Piperidine-1-propanesulfonic acid;1-PIPERIDINEPROPANESULFONIC ACID;3-(Piperidin-1-yl)propane-1-sulfonic acid
4 prices
Selected condition:
Brand
- AK Scientific
- Matrix Scientific
- Sigma-Aldrich
Package
- 50mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number2201BA
- Product description1-PIPERIDINEPROPANESULFONIC ACID
- Packaging500mg
- Price$936
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number121967
- Product description3-(Piperidin-1-yl)propane-1-sulfonicacid >95%
- Packaging500mg
- Price$657
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number121967
- Product description3-(Piperidin-1-yl)propane-1-sulfonicacid >95%
- Packaging1g
- Price$889
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS551732
- Product description1-PIPERIDINEPROPANESULFONIC ACID Aldrich
- Packaging50mg
- Price$106
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 2201BA | 1-PIPERIDINEPROPANESULFONIC ACID | 500mg | $936 | 2021-12-16 | Buy |
Matrix Scientific | 121967 | 3-(Piperidin-1-yl)propane-1-sulfonicacid >95% | 500mg | $657 | 2021-12-16 | Buy |
Matrix Scientific | 121967 | 3-(Piperidin-1-yl)propane-1-sulfonicacid >95% | 1g | $889 | 2021-12-16 | Buy |
Sigma-Aldrich | S551732 | 1-PIPERIDINEPROPANESULFONIC ACID Aldrich | 50mg | $106 | 2023-06-20 | Buy |
Properties
Density :1.218±0.06 g/cm3(Predicted)
pka :1.49±0.50(Predicted)
pka :1.49±0.50(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|